81_FR_54738 81 FR 54580 - Proposed Data Collection Submitted for Public Comment and Recommendations

81 FR 54580 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 158 (August 16, 2016)

Page Range54580-54581
FR Document2016-19461

Centers for Disease Control and Prevention as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on this proposed information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Executive and Scientific Resources Office Access Management System (EAMTS). EAMTS is designed to house all Guest Researcher & ORISE program packets, Appointment Mechanism Determination Forms, and Title 42 Fellowship Immigration information in one central location on the Human Resources Office SharePoint Server.

Federal Register, Volume 81 Issue 158 (Tuesday, August 16, 2016)
[Federal Register Volume 81, Number 158 (Tuesday, August 16, 2016)]
[Notices]
[Pages 54580-54581]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19461]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2016-0083; 60Day-16-16AWM]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: Centers for Disease Control and Prevention as part of its 
continuing efforts to reduce public burden and maximize the utility of 
government information, invites the general public and other Federal 
agencies to take this opportunity to comment on this proposed 
information collections, as required by the Paperwork Reduction Act of 
1995. This notice invites comment on the Executive and Scientific 
Resources Office Access Management System (EAMTS). EAMTS is designed to 
house all Guest Researcher & ORISE program packets, Appointment 
Mechanism Determination Forms, and Title 42 Fellowship Immigration 
information in one central location on the Human Resources Office 
SharePoint Server.

DATES: Written comments must be received on or before October 17, 2016.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0083 by any of the following methods: Federal eRulemaking Portal: 
Regulations.gov. Follow the instructions for submitting comments.
    Mail: Jeffrey M. Zirger, Acting Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Note: All public comment should be submitted through the Federal 
eRulemaking portal (Regulations.gov) or by U.S. mail to the address 
listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Data Management for Executive and Scientific Resources Access 
Management Tracking System--New--Executive and Scientific Resource 
Office (ESRO), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    ESRO seeks to submit and information collection request for 
approval of information collections through its ESRO Access Management 
Tracking System (EAMTS). This system will automate current manual 
processes for programs managed by ESRO. This new process will provide 
users a single, integrated location to allow for collaboration, faster 
processing between the programs and ESRO and a better onboarding 
experience for potential fellows.
    EAMTS will support users by providing a single, integrated location 
for enterprise content management, manage documents and records by 
using workflows an information rights management. This business process 
will allow ESRO to design forms that are accessible in SharePoint 
through a Web Browser. Team members will be able to access critical 
business information, analyze and view data, and publish reports to 
make more informed decisions.
    EAMTS will allow CIO's to submit digital packets including Guest 
Researcher, ORISE, Title 42 Fellowship Visa request (portion of CDC 
0.1475) and Appointment Mechanism Determination Request Form (CDC 
0.4601). CIO's can upload supplemental documentation as an attachment 
to each application, electronically track and monitor status of 
application, digitally sign forms and requests, receive case 
determinations quickly and accurately, and track the Visa status of 
Title 42 Fellowship requests that require Visa assistance from the 
Human Resources Office.
    EAMTS is developed in SharePoint for CDC's Centers/Institutes/
Offices (CIO) to submit required information for all of Executive and 
Scientific Resource Office's managed programs and for these CIO's to 
effectively and efficiently digitally review this information. Data is 
managed and maintained by appropriate CIO Staff with ground and form 
level permission.
    Permissions to EAMTS are required to access the lists, forms, and 
document library. This includes entering data,

[[Page 54581]]

clearing/approving forms, processing forms, and acknowledging data 
entered.
    The total estimated annualized burden hours for all respondents are 
1,280. There are no costs to respondents other than their time. CDC 
will seek a three-year approval from OMB.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents         CIO         (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Initiator/C/I/O...............  CDC 0.4601......              64               5               1             320
Initiator/C/I/O...............  CDC 0.410A......              64               5               1             320
Initiator/C/I/O...............  CDC 0.410B......              64               5               1             320
Initiator/C/I/O...............  Section C of the              64               5               1             320
                                 CDC 0.1475.
                                                 ---------------------------------------------------------------
    Totals....................  ................  ..............  ..............  ..............           1,280
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-19461 Filed 8-15-16; 8:45 am]
 BILLING CODE 4163-18-P



                                                    54580                        Federal Register / Vol. 81, No. 158 / Tuesday, August 16, 2016 / Notices

                                                    Leroy A. Richardson,                                      Note: All public comment should be                  the collection of information; and to
                                                    Chief, Information Collection Review Office,            submitted through the Federal eRulemaking             transmit or otherwise disclose the
                                                    Office of Scientific Integrity, Office of the           portal (Regulations.gov) or by U.S. mail to the       information.
                                                    Associate Director for Science, Office of the           address listed above.
                                                    Director, Centers for Disease Control and                                                                     Proposed Project
                                                                                                            FOR FURTHER INFORMATION CONTACT:              To
                                                    Prevention.                                                                                                     Data Management for Executive and
                                                                                                            request more information on the
                                                    [FR Doc. 2016–19460 Filed 8–15–16; 8:45 am]                                                                   Scientific Resources Access
                                                                                                            proposed project or to obtain a copy of
                                                    BILLING CODE 4163–18–P
                                                                                                            the information collection plan and                   Management Tracking System—New—
                                                                                                            instruments, contact the Information                  Executive and Scientific Resource Office
                                                                                                            Collection Review Office, Centers for                 (ESRO), Centers for Disease Control and
                                                    DEPARTMENT OF HEALTH AND                                                                                      Prevention (CDC).
                                                                                                            Disease Control and Prevention, 1600
                                                    HUMAN SERVICES
                                                                                                            Clifton Road NE., MS–D74, Atlanta,                    Background and Brief Description
                                                    Centers for Disease Control and                         Georgia 30329; phone: 404–639–7570;
                                                                                                            Email: omb@cdc.gov.                                      ESRO seeks to submit and
                                                    Prevention
                                                                                                            SUPPLEMENTARY INFORMATION: Under the                  information collection request for
                                                    [Docket No. CDC–2016–0083; 60Day–16–                    Paperwork Reduction Act of 1995 (PRA)                 approval of information collections
                                                    16AWM]                                                                                                        through its ESRO Access Management
                                                                                                            (44 U.S.C. 3501–3520), Federal agencies
                                                                                                            must obtain approval from the Office of               Tracking System (EAMTS). This system
                                                    Proposed Data Collection Submitted                                                                            will automate current manual processes
                                                    for Public Comment and                                  Management and Budget (OMB) for each
                                                                                                            collection of information they conduct                for programs managed by ESRO. This
                                                    Recommendations                                                                                               new process will provide users a single,
                                                                                                            or sponsor. In addition, the PRA also
                                                    AGENCY: Centers for Disease Control and                 requires Federal agencies to provide a                integrated location to allow for
                                                    Prevention, Department of Health and                    60-day notice in the Federal Register                 collaboration, faster processing between
                                                    Human Services.                                         concerning each proposed collection of                the programs and ESRO and a better
                                                    ACTION: Notice with comment period.                     information, including each new                       onboarding experience for potential
                                                                                                            proposed collection, each proposed                    fellows.
                                                    SUMMARY:    Centers for Disease Control                 extension of existing collection of                      EAMTS will support users by
                                                    and Prevention as part of its continuing                information, and each reinstatement of                providing a single, integrated location
                                                    efforts to reduce public burden and                     previously approved information                       for enterprise content management,
                                                    maximize the utility of government                      collection before submitting the                      manage documents and records by using
                                                    information, invites the general public                 collection to OMB for approval. To                    workflows an information rights
                                                    and other Federal agencies to take this                 comply with this requirement, we are                  management. This business process will
                                                    opportunity to comment on this                          publishing this notice of a proposed                  allow ESRO to design forms that are
                                                    proposed information collections, as                    data collection as described below.                   accessible in SharePoint through a Web
                                                    required by the Paperwork Reduction                        Comments are invited on: (a) Whether               Browser. Team members will be able to
                                                    Act of 1995. This notice invites                        the proposed collection of information                access critical business information,
                                                    comment on the Executive and                            is necessary for the proper performance               analyze and view data, and publish
                                                    Scientific Resources Office Access                      of the functions of the agency, including             reports to make more informed
                                                    Management System (EAMTS). EAMTS                        whether the information shall have                    decisions.
                                                    is designed to house all Guest                          practical utility; (b) the accuracy of the               EAMTS will allow CIO’s to submit
                                                    Researcher & ORISE program packets,                     agency’s estimate of the burden of the                digital packets including Guest
                                                    Appointment Mechanism Determination                     proposed collection of information; (c)               Researcher, ORISE, Title 42 Fellowship
                                                    Forms, and Title 42 Fellowship                          ways to enhance the quality, utility, and             Visa request (portion of CDC 0.1475)
                                                    Immigration information in one central                  clarity of the information to be                      and Appointment Mechanism
                                                    location on the Human Resources Office                  collected; (d) ways to minimize the                   Determination Request Form (CDC
                                                    SharePoint Server.                                      burden of the collection of information               0.4601). CIO’s can upload supplemental
                                                    DATES: Written comments must be                         on respondents, including through the                 documentation as an attachment to each
                                                    received on or before October 17, 2016.                 use of automated collection techniques                application, electronically track and
                                                    ADDRESSES: You may submit comments,                     or other forms of information                         monitor status of application, digitally
                                                    identified by Docket No. CDC–2016–                      technology; and (e) estimates of capital              sign forms and requests, receive case
                                                    0083 by any of the following methods:                   or start-up costs and costs of operation,             determinations quickly and accurately,
                                                    Federal eRulemaking Portal:                             maintenance, and purchase of services                 and track the Visa status of Title 42
                                                    Regulations.gov. Follow the instructions                to provide information. Burden means                  Fellowship requests that require Visa
                                                    for submitting comments.                                the total time, effort, or financial                  assistance from the Human Resources
                                                       Mail: Jeffrey M. Zirger, Acting                      resources expended by persons to                      Office.
                                                    Information Collection Review Office,                   generate, maintain, retain, disclose or                  EAMTS is developed in SharePoint
                                                    Centers for Disease Control and                         provide information to or for a Federal               for CDC’s Centers/Institutes/Offices
                                                    Prevention, 1600 Clifton Road NE., MS–                  agency. This includes the time needed                 (CIO) to submit required information for
                                                    D74, Atlanta, Georgia 30329.                            to review instructions; to develop,                   all of Executive and Scientific Resource
                                                       Instructions: All submissions received               acquire, install and utilize technology               Office’s managed programs and for these
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    must include the agency name and                        and systems for the purpose of                        CIO’s to effectively and efficiently
                                                    Docket Number. All relevant comments                    collecting, validating and verifying                  digitally review this information. Data is
                                                    received will be posted without change                  information, processing and                           managed and maintained by appropriate
                                                    to Regulations.gov, including any                       maintaining information, and disclosing               CIO Staff with ground and form level
                                                    personal information provided. For                      and providing information; to train                   permission.
                                                    access to the docket to read background                 personnel and to be able to respond to                   Permissions to EAMTS are required to
                                                    documents or comments received, go to                   a collection of information, to search                access the lists, forms, and document
                                                    Regulations.gov.                                        data sources, to complete and review                  library. This includes entering data,


                                               VerDate Sep<11>2014   18:36 Aug 15, 2016   Jkt 238001   PO 00000   Frm 00031   Fmt 4703   Sfmt 4703   E:\FR\FM\16AUN1.SGM   16AUN1


                                                                                          Federal Register / Vol. 81, No. 158 / Tuesday, August 16, 2016 / Notices                                                                                                 54581

                                                    clearing/approving forms, processing                                        The total estimated annualized                                              other than their time. CDC will seek a
                                                    forms, and acknowledging data entered.                                    burden hours for all respondents are                                          three-year approval from OMB.
                                                                                                                              1,280. There are no costs to respondents

                                                                                                                             ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                                                        Average
                                                                                                                                                                                                          Number of
                                                                                                                                                                               Number of                                              burden per              Total burden
                                                              Type of respondents                                                  Form name                                                            responses per
                                                                                                                                                                              respondents                                              response                (in hours)
                                                                                                                                                                                                             CIO                       (in hours)

                                                    Initiator/C/I/O    .....................................   CDC 0.4601 .....................................                                  64                           5                          1             320
                                                    Initiator/C/I/O    .....................................   CDC 0.410A .....................................                                  64                           5                          1             320
                                                    Initiator/C/I/O    .....................................   CDC 0.410B .....................................                                  64                           5                          1             320
                                                    Initiator/C/I/O    .....................................   Section C of the CDC 0.1475 ..........                                            64                           5                          1             320

                                                         Totals .........................................      ...........................................................   ........................   ........................   ........................          1,280



                                                    Leroy A. Richardson,                                                      Bethesda, MD 20892–9823, (240) 669–5069,                                      Reference No. E–157–2011/0–US–01],
                                                    Chief, Information Collection Review Office,                              lrust@niaid.nih.gov.                                                          status: Expired;
                                                    Office of Scientific Integrity, Office of the                             (Catalogue of Federal Domestic Assistance                                        International Patent Application No.
                                                    Associate Director for Science, Office of the                             Program Nos. 93.855, Allergy, Immunology,                                     PCT/US2012/32772 filed April 9, 2012
                                                    Director, Centers for Disease Control and                                 and Transplantation Research; 93.856,                                         titled ‘‘Small molecule therapeutic
                                                    Prevention.                                                               Microbiology and Infectious Diseases
                                                                                                                              Research, National Institutes of Health, HHS)
                                                                                                                                                                                                            compounds targeting thioesterase
                                                    [FR Doc. 2016–19461 Filed 8–15–16; 8:45 am]
                                                                                                                                                                                                            deficiency disorders and methods of
                                                    BILLING CODE 4163–18–P                                                      Dated: August 10, 2016.                                                     using the same’’ [HHS Reference No. E–
                                                                                                                              Natasha M. Copeland,                                                          157–2011/0–PCT–02], status: Converted;
                                                                                                                              Program Analyst, Office of Federal Advisory                                      European Patent Application No.
                                                    DEPARTMENT OF HEALTH AND                                                  Committee Policy.                                                             12716889.6, filed November 7, 2013,
                                                    HUMAN SERVICES                                                            [FR Doc. 2016–19417 Filed 8–15–16; 8:45 am]                                   titled ‘‘Small molecule therapeutic
                                                    National Institutes of Health                                             BILLING CODE 4140–01–P                                                        compounds targeting thioesterase
                                                                                                                                                                                                            deficiency disorders and methods of
                                                    National Institute of Allergy and                                                                                                                       using the same’’ [HHS Reference No. E–
                                                    Infectious Diseases; Notice of Closed                                     DEPARTMENT OF HEALTH AND                                                      157–2011/0–EP–03], status: Pending;
                                                    Meeting                                                                   HUMAN SERVICES                                                                and
                                                                                                                                                                                                               United States Patent Application No.
                                                      Pursuant to section 10(d) of the                                        National Institutes of Health
                                                                                                                                                                                                            14/110,393, filed October 7, 2013, titled
                                                    Federal Advisory Committee Act, as                                                                                                                      ‘‘Small molecule therapeutic
                                                    amended (5 U.S.C. App.), notice is                                        Prospective Grant of Start-Up
                                                                                                                              Exclusive Evaluation Option License                                           compounds targeting thioesterase
                                                    hereby given of the following meeting.                                                                                                                  deficiency disorders and methods of
                                                      The meeting will be closed to the                                       Agreement: Small Molecule
                                                                                                                              Therapeutic Compounds                                                         using the same’’ [HHS Reference No. E–
                                                    public in accordance with the                                                                                                                           157–2011/0–US–04], status: Pending.
                                                    provisions set forth in sections                                          Encompassed Within the Licensed
                                                                                                                              Patent Rights for the Treatment of                                               The patent rights in these inventions
                                                    552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                                                                                                              have been assigned and/or exclusively
                                                    as amended. The grant applications and                                    Thioesterase Deficiency Disorder
                                                                                                                                                                                                            licensed to the government of the
                                                    the discussions could disclose                                            AGENCY:         National Institutes of Health,                                United States of America.
                                                    confidential trade secrets or commercial                                  HHS.                                                                             The territory of the prospective Start-
                                                    property such as patentable material,                                                                                                                   Up Exclusive Evaluation Option License
                                                    and personal information concerning                                       ACTION:        Notice.
                                                                                                                                                                                                            Agreement may be worldwide and the
                                                    individuals associated with the grant                                                                                                                   field of use may be limited to: ‘‘Small
                                                    applications, the disclosure of which                                     SUMMARY:   This notice, in accordance
                                                                                                                              with 35 U.S.C. 209 and 37 CFR part 404,                                       molecule therapeutic compounds
                                                    would constitute a clearly unwarranted                                                                                                                  encompassed within the Licensed
                                                    invasion of personal privacy.                                             that the National Institutes of Health,
                                                                                                                              Department of Health and Human                                                Patent Rights for the treatment of
                                                      Name of Committee: National Institute of                                Services, is contemplating the grant of a                                     thioesterase deficiency disorders’’
                                                    Allergy and Infectious Diseases Special                                                                                                                    Upon the expiration or termination of
                                                                                                                              Start-Up Exclusive Evaluation Option
                                                    Emphasis Panel; NIAID Clinical Trial                                                                                                                    the Start-up Exclusive Evaluation
                                                    Implementation Cooperative Agreement                                      License Agreement to practice the
                                                                                                                              inventions embodied in the following                                          Option License Agreement, Circumvent
                                                    (U01).
                                                      Date: September 22, 2016.                                               Patent Applications to Circumvent                                             will have the exclusive right to execute
                                                      Time: 10:00 a.m. to 12:00 p.m.                                          Pharmaceuticals Inc. (‘‘Circumvent’’)                                         a Start-Up Exclusive Patent License
                                                      Agenda: To review and evaluate grant                                    located in Pasadena, California, USA:                                         Agreement which will supersede and
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    applications.                                                                                                                                           replace the Start-up Exclusive
                                                      Place: National Institutes of Health, Room                              Intellectual Property                                                         Evaluation Option License Agreement,
                                                    3F100, 5601 Fishers Lane, Rockville, MD                                      United States Provisional Patent                                           with no greater field of use and territory
                                                    20892 (Telephone Conference Call).                                                                                                                      than granted in the Start-up Exclusive
                                                      Contact Person: Lynn Rust, Ph.D.,
                                                                                                                              Application No. 61/473,692, filed April
                                                                                                                              8, 2011, titled ‘‘Small molecule                                              Evaluation Option License Agreement.
                                                    Scientific Review Officer, Scientific Review
                                                    Program, Division of Extramural Activities,                               therapeutic compounds targeting                                               DATES: Only written comments and/or
                                                    Room 3G42A, National Institutes of Health/                                thioesterase deficiency disorders and                                         applications for a license which are
                                                    NIAID, 5601 Fishers Lane, MSC 9823,                                       methods of using the same’’ [HHS                                              received by the NIH Office of


                                               VerDate Sep<11>2014      18:36 Aug 15, 2016           Jkt 238001       PO 00000        Frm 00032        Fmt 4703        Sfmt 4703      E:\FR\FM\16AUN1.SGM               16AUN1



Document Created: 2016-08-16 03:20:41
Document Modified: 2016-08-16 03:20:41
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesWritten comments must be received on or before October 17, 2016.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS- D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation81 FR 54580 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR